Wednesday, September 25, 2013

EU Okays Novel Drugs for Breast and Prostate Cancer Zosia Chustecka Disclosures Sep 20, 2013

In the European Union, the Committee for Medicinal Products for Human Use (CHMP) has recommended 2 novel cancer drugs for approval — trastuzumab emtansine (Kadcyla, Roche) for the treatment of metastatic breast cancer, and radium-223 chloride (Xofigo, Bayer) for the treatment of castration-resistant prostate cancer. Both have been shown to prolong survival.



Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More

Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review